Related Experiment Video
Updated: Sep 9, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Programmed Cell Death Networks in Tuberculosis: From Molecular Crosstalk to Lesion Immunopathology and Host-Directed
1Department of Pulmonary and Critical Care Medicine at the Seventh Medical Center, Chinese PLA General Hospital, Beijing, 100700, China; College of Pulmonary and Critical Care Medicine of the Eighth Medical Center, Chinese PLA General Hospital, Beijing, 100091, China.
Abstract:
Mycobacterium tuberculosis (M. tuberculosis) has evolved to survive within host phagocytes while provoking inflammatory tissue destruction, a delicate balance that is critically shaped by programmed cell death (PCD). Rather than acting as isolated linear pathways, apoptosis, necroptosis, pyroptosis, ferroptosis, autophagy/xenophagy, ETosis/NETosis, PARP1-AIF/parthanatos-related signaling, and PANoptosis-related signaling form an interconnected network that determines macrophage fate, granuloma integrity, bacterial dissemination, and immunopathology. In this Review, we discuss how M. tuberculosis and host-derived signals engage canonical cell-death modules, including caspases, RIPK1/RIPK3-MLKL, inflammasomes-gasdermins, ROS-iron-lipid peroxidation circuits, PARP1-AIF signaling, and autophagy machinery. We highlight context-dependent effects whereby apoptosis and autophagy may promote bacterial containment, whereas necrotic and inflammatory forms of death can either enhance antimicrobial immunity or drive caseation and tissue damage. We further evaluate emerging evidence for crosstalk among PCD modalities, with particular attention to shared molecular checkpoints and the still-evolving concept of PANoptosis in tuberculosis. Finally, we discuss host-directed therapeutic strategies aimed at recalibrating, rather than simply blocking or activating, cell-death pathways. A network-based understanding of PCD in M. tuberculosis infection provides a crucial framework for developing adjunctive therapies that enhance pathogen control while limiting destructive inflammation. Unlike pathway-centered summaries, this Review reframes M. tuberculosis-induced cell death as a dynamic network in which shared molecular hubs, compensatory switching, and lesion-stage-specific microenvironments jointly determine disease outcome.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

